1. A JC is an academic session in which we go through a scientific article over 60-90 min.
2. It takes place every Friday via our JC Discord channel โ see calendar.
3. Its purpose is to:
- Understand, discuss and dissect relevant elements from the content.
- Appraise whether they apply to or change our clinical practice.
- Identify learning opportunities and potential research questions.
4. The selected article for the week is posted in our dedicated WhatsApp group.
5. We take interactive and pedagogic notes in a shared document, using visual aids, highlighting, underlining, arrows, and conceptual links to connect ideas and facilitate understanding.
6. For each session, we create RECAP key points and publish them on our website.
7. In the following session, we briefly recall the previous JCโs RECAP to reinforce learning through retrieval practice.
Brief scope glossary
- ๐๐๐พ BS ๐ฐ ๐๐๐ผ๐ผ๐๐พ แดฎแดผ brief scope ๐ฐ Y, J, C โ T โ N โ t โ P I C O:
- year (Y), journal (J), country (C) โ type of study (T) โ patients/sample number (N) โ time (t) โ population (P), intervention (I), comparison (C), outcome (OC).
๐ซ๐ฝ = abdomen = abdominal, ๐ค = analysis, ๐ = arrhythmia, ๐ฉธ = blood = hematology, ๐ง = brain, โก๏ธ = cardiac arrest, โญ๏ธ = circulation, โ = decrease, ๐๐ซ = exclusion, ๐จ = flow, ๐ซ = heart, โ๏ธ = improve, ๐๐ก = inclusion, โ = increase, ๐ฅ = inflammation, ๐ชฒ = infections, โพ๏ธ = kidneys = renal, โธ = liver = hepatic, ๐ซ = lungs, ๐ช๐ฝ = muscle, โฐ = pressure, ๐ณ๏ธ = prevention, โ = recommendation(s), โ๐ฝ = stop, ๐ฃ = suggestion(s), โ๏ธ = worsen, CIpxs = critically ill patients, DX = diagnosis, h_LOS = Hospital length of stay, icu_LOS = ICU length of stay, inc_ = incident, MA = metaanalysis, mc = multicentric, MM = mortality, MM90 = mortality at 90 days, pOC = primary outcome(s), pxs = patients, RCT = randomized controlled trial, sOC = secondary outcome(s), sr = systematic review, SS = survival, w_ = with, wo_ = without, yo = years old.
Complete glossary here
โณ TIME MANAGEMENT.
01:43:52
Round: 9 00:53:23 Comments
Round: 8 42:13:02 Interpretation all
Round: 7 08:52:45 Interpretation
Round: 6 02:51:21 I: read + notes
Round: 5 05:10:92 Structure
Round: 4 19:19:16 Reading + notes + interpretation
Round: 3 06:37:83 ART selection
Round: 2 00:35:50 Comments
Round: 1 17:19:20 Past JC
โณ TIME MANAGEMENT.
01:39:50
Round: 11 01:09:41 Comments
Round: 10 40:00:54 Wrap-up
Round: 9 14:52:95 Interpretation
Round: 8 02:56:81 Reading + notes
Round: 7 08:52:19 Interpretation
Round: 6 04:12:06 REading + notes
Round: 5 11:53:50 Interpretation
Round: 4 03:10:69 Reading + notes
Round: 3 04:19:05 ART selection
Round: 2 00:55:75 Comments
Round: 1 07:27:80 Past JC
โณ TIME MANAGEMENT.
01:29:16
Round: 10 01:59:19 Comments
Round: 5 15:02:89 Wrap-up
Round: 4 07:09:52 Interpretation
Round: 3 05:49:09 Reading + notes
Round: 2 03:07:86 ART selection
Round: 1 07:57:68 Past JC + 10min
Friday, March 27, 2026 at 17:05:30 in BE
LH, EQO, HIBN, MASP, AAQC
2026 AIC - Subphenotyping hypotension in early Sโข, A physiology-guided therapeutic approach (sanchez) [ed].pdf
Codified by YAPG
GLOSSARY: โ = recommendation(s), DAP = diastolic arterial pressure, DSI = diastolic shock index, HD = hemodynamics, Mech = mechanism, PP = pulse pressure, SAP = systolic arterial pressure, SV = stroke volume, artT = arterial tone, vT = vascular tone, venT = venous tone, ๐จ = perfusion, ๐ซ DYSF = cardiac dysfunction
1. Continuationโฆ
2. Subphenotypes (3)
a. โVOL
i. Mech โถ๏ธ ABSOLUTE โVOL โ INF โ preserved vT
ii. HD โถ๏ธ
1. โCO secondary to โSV โฉ โPP โฉ โMAP
a. PP = SAP - DAP
2. HR โ as a compensatory mech
3. DAP not โ (if vT is preserved)
iii. TTO response โถ๏ธ
1. When โBP + โ peripheral ๐จ โฉ FR is needed, to โ:
a. Stressed ๐ฉธ volume
b. venous return
c. SV
b. โ vT
i. Mech โถ๏ธ
1. โ artT + venT
2. Venous DILATION โฉ relative โVOL (redistribution: stressed โ unstressed ๐ฉธVOL)
ii. HD โถ๏ธ
1. Causes: โ DAP + โ DSI (DSI = HR/DAP)
2. MAP is โ
3. CO is variable, depending: DEGREE of โrelative โ VOLโ โ โ vT
4. TTO response โถ๏ธ
a. IF โโBP + peripheral โ๐จโ , NE is the TTO.
i.. alfa 1 - adrenergic
ii. โ artT โฉ โDAP + MAP
iii. โ venT โฉ moves ๐ฉธ โ stressed compartment.
c.๐ซ DYSF
i. Mech โถ๏ธ
1. ๐ซ depression โ Sโข
2. Impaired CONTRACTILITY
ii. HD โถ๏ธ
1. โ SV
2. โ PP
3. โ MAP
4. DAP preserved
5. DIFFICULT to distinguish FROM โVOL, so consider other factors:
a. context
b. previous ๐ซ DIS
c. CV comorbidities
d. Clinical findings (๐ซ edema)
6. ECHO is needed.
iii. TTO response โถ๏ธ
1. Inotropic.
d. MIXED
โณ TIME MANAGEMENT
02:29:16
Round: 10 01:59:19 Comments
Round: 9 11:47:81 Wrap-up
Round: 8 12:03:26 Interpretation
Round: 7 03:32:76 Reading + notes
Round: 6 01:17:72 Comments
Round: 5 15:02:89 Wrap-up
Round: 4 07:09:52 Interpretation
Round: 3 05:49:09 Reading + notes
Round: 2 03:07:86 ART selection
Round: 1 07:57:68 Past JR + 10min
2026 AIC - Subphenotyping hypotension in early Sโข, A physiology-guided therapeutic approach (sanchez) [ed].pdf
Codified by YAPG
Glossary: ACIP = CDC Advisory Committee for Immunization Practices, cHTA = chronic hypertension, CRT = capillary refill time, DAP = diastolic arterial presssure, DM = diabetes, DSI = diastolic shock index, DYSF = dysfunction, PP = pulse pressure, SAP = systolic arterial pressure, SI = shock index, VRBPAC = FDAโs Vaccines and Related Biological Products Advisory Committee
1. โ MAP โฉ poor OC
2. Sโข induced โBP โถ๏ธ
a. โ VOL โฉ preload
b. โ vascular tone โฉ afterload
c. ๐ซ DYSF โฉ contractility
d. Combination
3. Vasoplegia does NOT allow โ tissue perfusion
4. FLUID ACCUMULATION โฉ worse OC
5. Concerns โถ๏ธ need for early subphenotype-tailored therapeutic strategy.
6. Bedside variables to guide therapy:
a. CRT. Does not define โAP subphenotype alone, but CENTRAL to decision-making
i. Prolonged = need for therapy.
ii. Normal = correction of โโฐ unnecessary UNLESS other signs of โ๐จ (altered mental status)
iii. Its RESPONSE helps identify the underlying mech and the plan (continue โ change ).
b. PP.
i. โPP = โSV
ii. Arterial stiffness ๐จ
iii. Elderly + cHTA + DM โถ๏ธ โapparentlyโ normal (40-50 mmHg) ๐ฐ โSV
c. DAP.
i. Except โHR, โ DAP (<45-50) ๐ฐ โ vascular tone
d. DSI
i. HR / DAP.
ii. โDSI (>3) โถ๏ธ severe VASODILATION
iii. More reliably than โDAP
iv. โ SI โถ๏ธ HR / SAP.
4. P-PHY subphenotypes
a. โVOL
b. โ vascular tone
c. ๐ซ DYSF
1. ๐๐๐พ BS โฉ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2021, IJGO, UK โ srMA โ 2524, 59 IN โ -Nov 11, 2020 โ P I C O:
- P: hALT pregnant
- ๐
ธ: preg hALT
- ๐
ฒ: preg non-hALT
- O: pOC = hALT impact on LBW, SGA, SPTB | sOC = magnitude LBW
3. EVIDENCE.
4. METHODS.
- ๐๐ก โ
- ๐๐ซ โ
- RANDOM โ
- INTERV โ
5. RESULTS.
6. RATIONALE.7. LIMITATIONS.
Friday, March 13, 2026 at 16:31:12 in BE
MASP, AAQC, PFLC, MNVC
โณ TIME MANAGEMENT.
01:01:21
Round: 6 03:29:58 Comments
Round: 5 28:48:61 Interpretaion
Round: 4 09:56:25 Reading + notes
Round: 3 07:27:69 ART selection
Round: 2 01:37:51 Comments
Round: 1 10:01:43 Past JC
2026 BMJ - Careful ventilation in ARDS (Coudroy) [RCT].pdf
Codified by ๐๐๐ผ๐ผ๐๐พ แดฎแดผ (MASP)
Glossary: c-ARDS = COVID ARDS, d_ = duration, d_MV = duration of mechanical ventilation, EFF = efforts, hLOS = hospital length of stay, icuLOS = ICU length of stay, inspE = inspiratory effort, oDYS = organ dysfunction, Paw = airway pressure, Pinsp = inspiratory pressure, PSILI = patient self-induced lung injury, s&s = stress and strain, SOC = standard of care, s-t = short-term, VILI = ventilator- induced lung injury
1. ๐๐๐พ BS โฉ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2026, BMJo, ARG + CA + CL + FR + IT + ES + NL + US โ invest-led_mc_ol_RCT (basket) โ 740 โ 6y (Nov 2020 - Jul 2026) โ P I C O:
๐ ฟ: ARDS & c-ARDS
๐ ธ: 2 ventilatory strategies
๐ ฒ: SOC
๐
พ: pOC = MM60 | sOC = d_MV โ d_icuLOS & hLOS
3. EVIDENCE
a. 10% of ICU admissions is ARDS
b. 23% of ventilated pxs is ARDS
c. s-t MM is 40% ๐ณ
d. Causes: ๐ซ , Sโข, TRAUMA, pancreatitis
e. ๐ซ โฉ inflamed + edematosos โฉ โ volume + compliance โถ๏ธ difficult ventilation
f. MV can cause VILI โฉ adverse HD consequences
g. c-ARD โฉ severe form โ complex physiology โ varies widely โ โ
uncertain. โถ๏ธ โ โ โ MM
h. NO TTO for the alveolar-capillary leak
i. YES supportive TTO โฉ MV โ NMB โ prone
j. RCT โถ๏ธ GL โถ๏ธ โr VILI w_: โVt โ โPaw โฉ โ stress & strain
k. Other STUDIES โถ๏ธ contemporary strategies are NOT SUFFICIENTLY protective.
l. PEEP is not used properly:
i. โ atelectrauma ๐ฐ opening + closing of alveoli
ii. โ recruitment ๐ฐ โ aerated ๐ซ โโ โ s&s
m. โ โ โ PEEP โฉ โMM [when alveoli NOT recruitable]
n. Authos described a technique to measure ALVEOLAR RECRUITABILITY
o. Spontaneous breathing & assisted MV โฉ PSILI
p. ๐ซ DRIVE โถ๏ธ โ ๐ซ โ systemic INFLAMMATION โ unmyelinated afferent fibres โ slow & rapid adaptive receptors (nociceptive stimuli + blunted โ response).
i. โ in ARDS pxs
ii. โ โ in c-ARDS pxs
iii. โ โd_MV
iv. โ MM
q. ๐ซ inspE โถ๏ธ โ distending (transpulmonary) pressure โถ๏ธ ๐ซ ๐ฅ โ oDYS
r. HYPOTHESIS: ๐ซ injury โ โ SS โ
i. individualizing PEEP
ii. โ MAX Pinsp
iii. โ magnitude spontaneous breathing EFF
s. PEEP
i. Set wo_knowledge of the potential of recruit โ only set on O2
ii. โ RCTs compared 2 levels of PEEP โฉ BUT, none looked at ๐ซ recruitment.
iii. Noncrecuitable ๐ฐ r_overdistention
iv. Recruitable ๐ฐ repetitive ๐ซ open-close
v. โ
โฉ โ PEEP but individual โ
vary.
vi. List
4. SOURCE: https://pubmed.ncbi.nlm.nih.gov/41730551/
โณ TIME MANAGEMENT.
02:29:16
Round: 10 01:59:19 Comments
Round: 9 11:47:81 Wrap-up
Round: 8 12:03:26 Interpretation
Round: 7 03:32:76 Reading + notes
Round: 6 01:17:72 Comments
Round: 5 15:02:89 Wrap-up
Round: 4 07:09:52 Interpretation
Round: 3 05:49:09 Reading + notes
Round: 2 03:07:86 ART selection
Round: 1 07:57:68 Past JR + 10min
Friday, April 24, 2026 at 18:35:53 in BE
TGA, MASP, AAQC, HIBN
2026 AIC - Subphenotyping hypotension in early Sโข, A physiology-guided therapeutic approach (sanchez) [ed].pdf
Codified by YAPG
Glossary: d_ = during, FR = fluiid responsiveness, hLOS = hospital lenght of stay, iFR = fluid responsiveness indices, ivT-R = indices of vascular tone responsiveness, rโi = responsiveness or intolerance, SUPP = support, VA = vasoactives, ยตCIR = microcirculatory, ๐ซ = heart, ๐ซ = lungs
1. Mixed subphenotypes:
a. SEPSIS โฉ combinations:
i. โVOL + โvT
1. โ PP + โ DAP
2. TTO โฉ fluids + NE
3. Delaying NE is RISKY โถ๏ธ
a. fluids may worsen VASODILATION.
b. early NE movilizes VENOUS BLOOD
ii. ๐ซDYSF + โvT โ ๐ซDYSF + โVOL. Before DOBUTAMINE:
1. Dx ๐ซ DYSF should be WELL STABLISHED.
2. ANY โVOL โ โvT SHOULD BE corrected. If Dobuta:
a. Poorly tolerated.
b. โ๏ธ โvT
iii. MIXED 3 mechs โฉ varying proportions (emerging + receding + combining to โ degrees)
2. Beyond early subphenotyping
a. Subphenotying is not all.
b. Additional considerations:
i. MAP targets
ii. FR rโi
iii. VP rโi
iv. Evolving ยตCIR behavior
v. need ongoing ADJUSTMENT
c. Advanced clinical TOOL
i. ScvO2
ii. โCO2
iii. iFR
iv. ivT-R
v. VExUS
d. More invasive HD monitoring โฉ in COMPLEX CASES
i. unresponsive to initial therapy
ii. fluid benefit-risk assessment (e.g. ARDS)
e. Integration of all โฉ implementation of a PESRONALIZED, PX TAILORED APPROACH.
3. CLIINICAL IMPLICATIONS
a. Subphenotyping is a KEY STEP โ precision resuscitation.
b. When combined w_CLINICAL CONTEXT โ SIMPLE BEDSIDE MARKERS ๐ฐ ID mechs โถ๏ธ administer fluids, VP, INO, โ combination.
c. Recent evidence โถ๏ธ ANDROMEDA-SHOCK-2
i. โ OC
ii. ๐
ธ CRT-PHR = personalized hemodynamic resuscitation protocol
targeting capillary refill time
iii. pOC = combined: MM โ d_vital SUPP (VA, MV, RRT) โ hLOS 28d
iv. ๐
ธ (better) ๐ usual care
โณ TIME MANAGEMENT.
01:48:07
Round: 7 01:11:38 Comments
Round: 6 21:12:56 Wrap-up
Round: 5 41:46:90 Interpretation
Round: 4 03:56:96 Reading + notes
Round: 3 00:14:59 Same topic
Round: 2 37:30:69 Continue wrap-up
Round: 1 02:13:96 Past JC
Friday, April 10, 2026 at 18:15:06 in BE
SR, HBN, EQO, MASP, AAQC
2026 ICM - Temporary mechanical support in fulminant myocarditis, prognostic factors + clinical implications, FULLMOON study (Schmidt) [R].pdf
Codified by YAPG
Glossary: AdvOC = adverse outcomes, EMB = endomyocardial biopsy, FM = fulminant myocarditis, HTx = heart transplantation, LVAD = left-ventricular assist device, t-MCS = temporary mechanical circulatory support, wOC = worse outcome.
1. ๐๐๐พ BS โฉ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2026, ICM, 15C โ cohort FULMOON (int_mc_retro_โregistryโ) โ 295/419 pxs (36 centers)โ Jan 2008 - Jan 2020 (12y) โ P I C O:
๐ ฟ: FM + V-A ECMO ยฑ impella
๐ ธ: NA
๐ ฒ: NA
๐
พ: pOC = MM 1y โ HTx โ LVAD
3. EVIDENCE
a. FULLMOON โถ๏ธ EHJ 2023, Huang et al. โฉ DX made by:
i. histologically = 50%
ii. autopsy = 28%
iii. MRI = 23%
b. t-MCS โถ๏ธ โ used in FM โฉ OC + rf are POORLY DEFINED.
4. METHODS.
5. RESULTS.
a. Age 39y (55% โ)
b. Confirmed 69% (histological + MRI)
c. Causes:
i. HTA
ii.๐ฉธ hh
iii. SSร
d. UNIVARIATE
i. diastolic HTA (RR 2,7. p=0.0001) AUROC 0,58. p=0.003
ii. severe bleeding > 1000mL (RR 11. p=0.0001) AUROC 0,56. p=0.03
iii. CRT > 3,5s (RR 14,2. p=0.0001) AUROC 0,72. p=0.001
e. MULTIVARIATE
i. severe bleeding > 1000mL
ii. CRT > 3,5s
f. Better RR with CRT.
Friday, May 29, 2026 at 18:14:30 in BE
TGA, KYEC, MLHG, HIBN, AAQC,
โณ TIME MANAGEMENT.
01:25:51
Round: 6 02:13:52 Comments
Round: 5 25:07:88 RECAP
Round: 4 36:11:17 Interpretation
Round: 3 09:30:58 Reading + notes
Round: 2 05:32:34 JR selection
Round: 1 07:16:23 Past JR
6. RATIONALE
a. Pregnancy is related to microcirculation derangements.
b. Sublingual alterations shown.
c. Strong prolonged CRT โ sublingual ยตCIR โฉ SSร
d. Current TTO might MODULATE this network.
7. SOURCE: Monares Zepeda et al. Critical Care https://doi.org/10.1186/s13054-025-05404-9 (2025) 29:231
2026 BMJ - CAVIARDS, careful ventilation in ARDS (Coudroy) [RCT].pdf
Codified by ๐๐๐ผ๐ผ๐๐พ แดฎแดผ (MASP)
Glossary: c-ARDS = COVID ARDS, d_ = duration, d_MV = duration of mechanical ventilation, EFF = efforts, hLOS = hospital length of stay, hPEEP = high PEEP, icuLOS = ICU length of stay, inspE = inspiratory effort, NRD = neural respiratory drive โฉ, oDYS = organ dysfunction, Paw = airway pressure, Pinsp = inspiratory pressure, Pplat = plateau pressure, PSILI = patient self-induced lung injury, Ptp = transpulmonary pressure, REC = recruitability, rf = risk factors, s&s = stress and strain, SOC = standard of care, s-t = short-term, VILI = ventilator- induced lung injury
1. ๐๐๐พ BS โฉ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2026, BMJo, ARG + CA + CL + FR + IT + ES + NL + US โ invest-led_mc_ol_RCT (basket) โ 740 โ 6y (Nov 2020 - Jul 2026) โ P I C O:
๐ ฟ: ARDS & c-ARDS
๐ ธ: 2 ventilatory strategies
๐ ฒ: SOC
๐
พ: pOC = MM60 | sOC = d_MV โ d_icuLOS & hLOS
3. EVIDENCE
a. 2 criteria to set PEEP (for this study):
i. R/I ratio โ for predicting alv_REC
ii. ยซOne-breath decremental PEEPยป โ distinguishes: recruitable ๐ non-recruitable
iii. <5min
iv. It should:
1. avoid harm of hPEEP (when not recruitable)
2. allow hPEEP only when recruitable
v. This happens when R/I >0.5.
b. Airway closure
i. Complete closure is >5 cmH2O โฉ 30-40% โฉ defines the minimum PEEP.
ii. Humans and animal might have the same damage.
iii. Pressure-time curve helps detecting it. (low-flow inflation)
iv. PRO: (due to better understanding of the alveoli than Paw)
1. avoiding repeated opening-closure.
2. corrects assessment of plateau + driving P
v. Necessary step BEFORE measuring recruitability.
c. Maximal inp distending P
i. Assessed by Pplat โ to titrate Vt
ii. GL โถ๏ธ limits Vt + Paw + PEEP
d. ๐ซ drive โ spontaneous breathing effort
i. D_SPONTANEOUS breathing: โ resp drive โ large resp efforts ๐ฐ PSILI + diaphragm DYS
ii. 2018 ICM, Brochardโฆ 2020 BLUE, Rittayamai โฉ P0.1
1. simple tool on ventilator
2. Reflects: NRD โฉ guide level os assistance + sedation.
3. โ โr: excessive Ptp โฉ โ rPSILI
iii. MECHS assessment CONTROLS the 3rf (underlined above)
iv. MECHS:
1. alveoli recruitability
2. R/I ratio
3. total PEEP
4. Pplat
5. โP
6. resp system COMPLIANCE
7. P0.1
e. HYPOTHESIS. individualizing ventilator setting based on RESP MECHS โ more effective โ๏ธ
โณ TIME MANAGEMENT.
01:22:05
Round: 7 02:33:44 Comments
Round: 6 29:57:18 RECAP
Round: 5 11:17:01 Interpretation
Round: 4 01:13:60 Reading + notes
Round: 3 23:06:18 Evidence (2nd part)
Round: 2 13:21:09 JC continuation
Round: 1 00:37:39 PAst JC
Friday, May 8, 2026 at 18:30:59 in BE
SC, TGA, RCH, BAR, DEPZ, YAPG, HIBN, AAQC,
2022 CC - Neostigmine for intraโabdominal hypertension in acute pancreatitis (he) [RCT]
Codified by ๐๐๐ผ๐ผ๐๐พ แดฎแดผ (AAQC)
Glossary: ACS = acute compartment syndrome, ADM = admission, AP = acute pancreatitis, CT = computed tomography, DIS = discharge, DYS = dysfunction, FLU = fluid balance, HD = hemodynamic, IAH = intra-abdominal hypertension, ITW = interview, NG = nasogastric, NJ = nasojejunal tube, OD = organ dysfunction, OF = organ failure, PCD = percutaneous catheter drainage, SAP = severe acute pancreatitis, sc = single center, Sx = surgery, UTI = urinary tract infection, WSACS = World Society for Abdominal Compartment Syndrome, ๐ก๐ข ๐๐๐๐ = no difference
1. ๐๐๐พ ๐จ๐๐ค๐ฅ๐ โถ๏ธ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2022, CC, CH ๐จ๐ณ (Nanchang) โ sc_pg_sup_pII_RCT โ 80 (40 x 40) โ Sep 2015 - Aug 2017 โ P I C O:
- ๐ ฟ: adults: AP + IAH (18 - 70 yo)
- ๐ ธ: neostigmina โ 1mg every 12h, 8h or 6hโฆ depending on response.
- ๐ ฒ: onventional TTO f_7d
- ๐ พ:
- pOC = % โIAP at 24h (efficacy)
- sOC = ๐ฉ โ stool volume, ACS, new-onset ACS, โ๏ธ IAH, new OD, MOD, MM, ๐ซ respiratory OF, ๐ซ circulatory OF, โพ๏ธ renal OF, ๐ฅฃ timing of EN, ๐ฉธ IA bleeding, ๐ซ๐ฝ enterocutaneous/enteric fistula, and ร.
3. EVIDENCE
a. IAH in AP โ ORGAN DYS
b. SAP โ โ MM
c. IAH = IAP โฅ12 mmHg (WSACS)
d. Prospective โถ๏ธ 37% MM โ AP + IAH (17% of IAH in AP)
e. Inflammatory state:
i. edema
ii. fluids collections
iii. ascites
iv. gut injury โ PARALYTIC ILEUS
v. gastric dilatation
f. When IAP >20mmHg โ ACS โ OD
g. Descompression โ morbidity
i. โ non-operative are preferred:
1. NG decompression
2. promotility agents
3. PCD
h. Neostigmine:
i. anti-cholinesterase
ii. โ๏ธ peristaltis
iii. promotes passage of FLATUS + defecation
iv. colonic decompression
v. WSACS โ ๐ ธ as TTO for colonic ileus IF no response to simple measures.
i. Colonic ileus CONFIRMATION (difficult to perfom in OD โ HD instability):
i. X-ray in standing position
ii. CT
j. IF conventional TTO fail โฉ think of paralytic ileus โ NEOSTIGMINE could help.
4. METHODS.
- IAH within 2 w of AP onset โ conventional TTO f_24h
- IAP โฅ12 mmHg
- H laparotomy
- IA bleeding
- contraindication neostigmin
- ๐ซ angina,
- MI,
- VT,
- bradycardia,
- acute circulatory failure;
- ๐ง epilepsy;
- ๐ซ bronchial asthma;
- ๐ซ๐ฝ mechanical intestinal obstruction,
- intestinal fistula;
- hyperthyroidism;
- ๐ serious
- intestinal fistula
- allergy to neostigmine.
- UTI โ bladder Sx
- Pregnancy & lactation
Friday, July 10, 2026 at 18:00:20 in BE
EQO, OWGG, YAPG, SLDC, HIBN, AAQC,
- NO DEFECATION
- initially โ every 12h
- a_12h โ every 8h
- a_24h โ every 6h
- STOP ๐ ธ
- IAP < 12mmHg
- IF not โ โฉ for 7d
- EN
- IAP <15mmHg โ NJ
- started 20mL/h โ โ 15mL x8h
- goal 25-35 Kcal/Kg/d โ depending on px TOLERANCE
- PN
- โฅ15mmHg
- SX decompression multidisciplinary seminar
- IAP > 25mmHg โ
- OD + fulminant ACS
- ฦ-up
- 1, 3, 6m af_DIS
- ITW โ telephone
DEFINITIONS โ
- Conventional TTO (for 24h)
- sedations + analgesia
- NG decompression
- glycerin enema
- negative fluid balance
- PCD for ascitis
- Concomitant TTO (intervention + ฦ-up)
- NG ยฑ rectal tube
- paraffin oil + liquid soaked + traditional Chinese medicine
- glycerin enema
- PCD for ascitis
- ๐ albumin, diuretics, RRT โ for fluid overload
- sedation + analgesia IF agitation + asynchrony
5. RESULTS.
a. Baseline โ ๐ก๐ข ๐๐๐๐
b. Rate of โ IAP (p = 0.017)
i. ๐ ธ faster โฉ -18,7%
ii. ๐ ฒ โฉ -5,4%
c. Subgroup IAP โฅ15mmHg (p = 0.018)F
i. ๐
ธ more pronounced
ii. ๐
ฒ
d. Per-protocol ๐ค โ CONFIRMED (p=0.03)
e. Stool volume d_7d (p<0.05)
i. ๐ ธ consistently higher
ii. ๐ ฒ
f. Other sOC โ ๐ก๐ข ๐๐๐๐
6. RATIONALE.
โณ TIME MANAGEMENT.
02:31:08
Round: 11 00:49:92 Comment
Round: 10 39:48:99 RECAP
Round: 9 01:04:09 Article
Round: 8 12:48:22 Interpretation
Round: 7 03:34:56 Introduction
Round: 6 18:13:34 RECAP
Round: 5 01:10:05 Comments
Round: 4 01:57:91 Interpretation
Round: 3 02:50:68 Reading + notes
Round: 2 01:34:47 ART proposed
Round: 1 04:11:28 Past JC
2026 LANCET - EMPHASIS, efficacy and safety of minocycline in pxs w_ acute ischaemic Sโ (Lu) [RCT].pdf
Codified by YAPG
Glossary: GUSTO-PAO-CA = Global Utilisation of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries, h_ = haemorrhagic, i_ = ischaemic, LOC = level of consciousness, mRS = modified Rankin Scale, OR = odds ratio, QOL = quality of life, TTO = treatment
1. ๐๐๐พ ๐จ๐๐ค๐ฅ๐ โถ๏ธ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2026, LANCET, CH ๐จ๐ณ โ mc_db_pla_RCT โ 1724 (862 ๐ 862) โ May 2023 - May 2024 (1y) โ P I C O:
- ๐ ฟ: adults, a_iSโ โคน72h
- ๐ ธ: minocycline
- ๐ ฒ: placebo
- ๐ พ: pOC = excellent functional OC โ mRS 0-1
- sOC =
- 90d mRS โ ordinal shift ๐ค
- 24h + 6d change NIHSS ๐ baseline
- 6d change hs-CRP ๐ baseline
- 24h + 6d early ๐ง deterioration
- 90d new Sโ (i_ + h_)
- 90d new i_Sโ
- 90d composite: Sโ + MI + v_MM
- 90d QOL โ EQ-5D
- funcional independence โ mRS โค2
- independent ambulation โ mRS โค3
- 24h + 6d icHH (at least 1) โ Heidelberg Bleeding Classification
- 6d ATB-associated โ diarrhoea + enteritis + constipation
- 90d any HH โ GUST-PAO-CA
- 90d v_MM
- 90d ac_MM
- 90d ร reported by investigator
3. EVIDENCE
a. Minocycline โ
i. muti-target anti-neuroinflammatory
ii. Potential benefits for i_Sโ โ preclinical + small-scale clinical studies
Friday, July 17, 2026 at 18:30:47
EQO, LCO, LPM, YAPG, SLDC, BAR, HIBN, AAQC,
4. DEFINITIONS
a. Dose = 200mg + 100mg every 12h f_4d
5. METHODS.
- NIHSS 4-25
- LOC (subscale 1a) โค1
- 1:1 + routine TTO
- fixed block size of 4 โ computer-generated
6. RESULTS.
a. 65yo โค 67% โ๏ธ
b. Baseline NIHSS = 5
c. Withdrew consent (4) + lost ฦ-up (19)
d. Excellent functional OC โ mRS 0-1 (p = 0.0061)
i. ๐ ธ 53%
ii. ๐ ฒ 47%
e. 90d mRS โ ordinal shift ๐ค (p = 0,018)
i. ๐
ธ โ๏ธ โ OR 1,19
ii. ๐
ฒ โ๏ธ
f. 24h + 6d icHH (at least 1) โ Heidelberg Bleeding Classification
i. ๐ก๐ข ๐๐๐๐
g. Other safety OC
i. ๐ก๐ข ๐๐๐๐
6. RATIONALE.
8. SOURCE: Lu Y, Guan L, Wu J, et al. Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial. Lancet. 2026;407(10529):679-688. doi:10.1016/S0140-6736(25)01862-8
โณ TIME MANAGEMENT.
01:49:06
Round: 6 02:02:35 Comments
Round: 5 56:51:76 RECAP
Round: 4 20:24:33 Interpretation
Round: 3 05:39:79 Reading + notes (abstract)
Round: 2 01:18:70 ART selection
Round: 1 22:49:77 Past JC
2022 CCM - Therapeutic Hyperthermia Is Associated w_Improved in Afebrile CIpxs w_ Sโข (Drewry) [RCT].pdf
Codified by YAPG
Glossary: CA = cancer, DIS = disease, โimm = immunosuppression, HLA = human leukocyte antigen, IFN = interferon gamma, L = lymphocytes, LPS = lipopolysaccharides, NK = natural killer, po_ = postoperative, r = risk, Sโข = sepsis, sc = single center, โคน = prior to
1. ๐๐๐พ ๐จ๐๐ค๐ฅ๐ โถ๏ธ Y, J, C โ T โ N โ t โ P I C O:
2. ๐๐๐พ BS ๐ฐ 2022, CCM, Washington ๐บ๐ธ โ sc_pros_ol_RCT โ 1200bed โ 56 pxs โ Mar 2016 - Apr 2019 (3y) โ P I C O:
- ๐ ฟ: MV_Sโข_adults
- ๐ ธ: โ Tยบ
- ๐ ฒ: standard Tยบ
- ๐
พ:
- pOC = monocyte HLA-DR expression
- sOC = CD3/CD28 induced IFN-โ production โ MM โ fd_H+28
- oth_OC = feasibility โ safety
3. EVIDENCE.
a. โTยบ โ๏ธ immune function
b. Fever โ
i. fewer than half in Sโข
ii. may be ADAPTIVE RESPONSE to INF โ โ๏ธ SS
c. Afebrile pxs โ 2x โMM โ more likely to INF
d. Animals + in vitro โถ๏ธ โTยบ โ โ:
i. Ab production
ii. T-cell โ
iii. macrophage function
iv. heat shock protein response
e. SEPSIS โ mechanisms PRO + ANTI-inflammatory โฉ ๐จ prolonged โimm
f. Biomarkers โ โimm
i. โ HLA-DR
ii. โ LPS TNF-โพ๏ธ
iii. โ anti-CD3/CD28-IFN-โ
iv. โ L
g. โimm persistent (compared to INTACT immunity):
i. โ MM
ii. โ INF
h. โ Tยบ:
i. immunomodulation in CA
ii. โ๏ธ function:
1. NK
2. dentritic cells
3. T cells
iii. perioperative warming
1. โ po_INF
4. DEFINITIONS
a. Severe Sโข (inicial 2001 consensus) ๐ sepsis 3 (post-hoc review)
5. METHODS.
- ๐ชฒ Sโข in 48h
- ๐ซ anticipated MV >48h
- ๐ sedation w_RASS <0 - ๐ก๏ธ MAX 38.3ยบC within 24h โคน
Friday, July 24, 2026 at 18:00:13
EQO, LCO, RMCF, YAPG, HIBN, AAQC,
- immunologic DIS
- immune-suppressing MEDs 6m
- corticosterids >300 mg/d hydrocortisone or โ
- Hep C โ C
- any condition sensitive to โTยบ (๐ง injury, etc.)
- pregnancy
- comfort TTO
- contraindication of warming
- other enrollment
6. RESULTS.
a. HLA-DR expression (p=0.396)
i. ๐ ธ 692
ii. ๐ ฒ 2002
iii. โ ๐ก๐ข ๐๐๐๐
b. IFN-โ production (p=0.678)
i. ๐
ธ 31
ii. ๐
ฒ 69
iii. โ ๐ก๐ข ๐๐๐๐
c. MM28 (95%CI -48 to -2)
i. ๐ ธ 18
ii. ๐ ฒ 43
iii. absolute r_โ 25%
d. fd_H+28 (95%CI 0-11,6)
i. ๐ ธ 13.1
ii. ๐ ฒ 0
iii. DIFF 2,6
7. RATIONALE.
8. SOURCE: Drewry AM, Mohr NM, Ablordeppey EA, et al. Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial. Crit Care Med. 2022;50(6):924-934. doi:10.1097/CCM.0000000000005470
โณ TIME MANAGEMENT.
01:48:38
Round: 10 04:12:00 Comments
Round: 9 35:16:62 Methods
Round: 8 15:18:52 RECAP
Round: 7 11:12:90 Interpretation
Round: 6 02:57:83 Reading + notes (Intro)
Round: 5 15:04:70 RECAP
Round: 4 10:04:06 Interpretation
Round: 3 03:19:78 Reading + notes (abstract)Round: 2 00:43:96 ART selectionRound: 1 10:27:78 Past JC
2026 JAMA - The Sodium Paradox in Decompensated HF (Biegus) [vp].pdf
Codified by ๐๐๐ผ๐ผ๐๐พ แดฎแดผ (YAPG)
Glossary: โ
= recommendation(s), ๐จ = flow = perfusion, ร = adverse effects, ESC-HF-A = European Society of Cardiology Heart Failure Association, HF = Heart FailurE, HTA = hypertension, HTS = hypertonic saline, MECHS = mechanisms, pPHY = pathophysiology, RAAS = renin-angiotensin-aldosterone system, supp = supplementation, UO = urine output, โ = consequently
1. Maladaptive handling โ CENTRAL โ pPHY of HF
2. 2 key OBS:
a. HOMEOSTASIS
i. impaired โ โ accumulation
ii. pxs cannot excrete it adequately
b. EXCESS
i. edema + ๐ซ congestion
ii. โexperimental exposureโ NaCl โ Na retention + congestion
c. โ REASONING
i. โ Na restriction should PREVENT further accumulation of Na + H2O โ โ congestion โถ๏ธ OFTEN FAILS TO DO SO
3. Na needed to โ โNa + H2Oโ
a. Considerations that contradicts (traditional paradigm):
i. Natriuresis:
1. positive relation w_UO
2. Na = critical fator in effective urine โ๏ธ
ii. Loop diuretics
1. act through โ Na dependen MECHS
iii. Regulators (Na + Cl)
1. intravascular tonicity
2. RAAS
3. diuresis
b. pPHY considerations:
i. Na helps PRESERVE โพ๏ธ function, through MODULATION:
1. RAAS
2. intraglomerular HTA
3. glomerular ๐จ
ii. All the previous remain THEORETICAL
c. Na AVAILABITY โ PROPER HANDLING
i. โฉ effective DECONGESTION.
ii. challenges CONVENTIONAL WISDOM
iii. demands REEXAMINATION in light of emerging clinical data.
Friday, August 21, 2026 at 19:18:09 CEST
BAR, SLMG, HIBN, AAQC,
4. BENEFIT โ Na+Cl supplemenation
a. NaCl supp โ decongestive benefits in decompensated HF
b. Relaxation of Na restriction โฉ โ ESC-HF-A document (Eur J Heart Fail. 2024)
c. Previous research โถ๏ธ limit Na intake (pxs + healthy):
i. โ natriuresis of furosemide
ii. โ diuretic tolerance
d. Animal models (shock) โถ๏ธ HTS
i. โ central hemodynamic
ii. โ visceral ๐จ
iii. โ UO
e. Salt supp โฉ โ neurohormonal drive (core MECH in pPHY HF)
f. โ โฉ sound good to USE NaCl supp
g. Real-world data โถ๏ธ HTS in diuretic-refractory HF:
i. โ diuretic effciency
ii. โ weigh loss
iii. โ๏ธ clinical + metabolic
iv. wo_ร
h. MA of RCTs โถ๏ธ benefit w_ โHTS+furoโ ๐ โfuro aloneโ:
i. diuresis
ii. natriuresis
iii. โ clinical end points
i. TARGET-1 โ TARGET-2 โถ๏ธ
i. Reprieve System
1. automated fluid mm system
2. monitors UO
3. returns a matched volume of 0.9% NaCl
4. maintains a set fluid balance
ii. ๐ ฟ decompensated HF pxs
iii. ๐ ธ Reprieve System therapy + diuretics
iv. ยฎ โ UO (6L/d) d_infusion ๐ 2L/day (day before)
v. ยฎ โ UO (2L/d) a_infusion
vi. โ1 โช๏ธ ๐ ฟ could
1. EXCRETE Na+H2O โ contradictory to traditional dogma
2. maintained a (-) balance Na-H2O โdespite or perhaps in response to supp
vii. โ2 โช๏ธ ๐ ฟ w_NaCl infusion could more effectively:
6. RESULTS.
1. EXCRETE Na
2. EXCRETE volume
viii. Set balance = 100mL/h net negative
j.
7. SOURCE:
โณ TIME MANAGEMENT.
01:28:09
Round: 8 01:05:47 Comments
Round: 7 22:12:32 RECAP
Round: 6 12:34:44 Interpretation 2
Round: 5 14:38:18 RECAP 1
Round: 4 12:28:92 Interpretation
Round: 3 09:47:87 Reading + notes
Round: 2 08:15:87 ART selectionRound: 1 07:06:73 Past JC
2024 JACP - Neuroprognostication After Cardiac Arrest (Kromm) [CP].pdf
Codified by ๐๐๐ผ๐ผ๐๐พ แดฎแดผ (MASP)
Glossary: af_ = after, CA = cardiac arrest, DX = diagnostic, diagnosis, DYSF = dysfunction, HIBI = hypoxic-ischemic brain injury, ischHepat = ischemic hepatitis, neuroPROG = neuroprognostication, TTO = treatment, WLST = withdrawal of life-sustaining therapies
1. UNCERTAINTY โฉ coma af_CA
a. DX
b. TTO
c. despite โ advances in TECH + RESUS CARE
d. How best to prognosticate?
2. GL โถ๏ธ variability in CLINICAL PRACTICE
3. Clinical case โ PRINCIPLES evaluated + APPROACH to neuroPROG
a. Clinical exam
b. Neuroimaging
c. Neurophysiology
d. Multimodal approach
e. Multidisciplinary team
4. INCIDENCE
a. OHCA 47,3 per 100k person/y
b. IHCA 1,8 per 1k admissions/y
5. COMATOSE postCA โฉ 80% โ HIBI
Friday, August 28, 2026 at 18:05:08 CEST
BAR, SLMG, HIBN, AAQC,
6. DEATH:
a. small proportion โ HD instability + MOD
b. frequent case โ WLST
7. Best practice to AVOID:
a. inappropriate WLST
b. premature WLST
c. harmful invDev
8. CLINICAL CASE
a. 56yo โ๏ธ
b. Unresponsive (drug paraphernalia)
c. Unwitnessed, asystolic OHCA
d. 10min CPR
e. 2x EPI
f. ROSC
g. H+ โ GCS 3 + โfixed & dilatedโ pupils.
h. CAUSE
i. drugs overdoseโฆ? โ opioids + BZD + metamphetamines urine
ii. ECG + ECHO + RX โ โ
iii. CT โ โ
iv. LAB โ AKI + ischHepat (mild synthetic DYSF)
v. ICU โ GCS 4 (motor 2โฆ 1, 1) + jerking movements (face + limbs)
i. TTO
i. levetiracetam
j. EEG
i. generalized slowing + suppression
ii. no epileptiform discharge or seizures
7. SOURCE: Kumar P, Kaur K. Neuroprognostication after cardiac arrest: Updated insights from the 2025 ERC-ESICM guidelines. J Anaesthesiol Clin Pharmacol. 2026;42(2):171-174. doi:10.4103/joacp.joacp_695_25
โณ TIME MANAGEMENT.
01:28:09
Round: 8 01:05:47 Comments
Round: 7 22:12:32 RECAP
Round: 6 12:34:44 Interpretation 2
Round: 5 14:38:18 RECAP 1
Round: 4 12:28:92 Interpretation
Round: 3 09:47:87 Reading + notes
Round: 2 08:15:87 ART selectionRound: 1 07:06:73 Past JC